Institutional Manager · CIK 0001791468
CHI Advisors LLC
NEW YORK, NY · File #028-19612
Latest AUM
$252.3M
Positions
28
Top-10 Concentration
81.3%
Filings
5
Sector Allocation
Filing History
View all filings →Top 20 Holdings — Dec 2023
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | PLIANT THERAPEUTICS INC | PLRX | 3,014,199 | $52.3M | 20.72% |
| 2 | REPARE THERAPEUTICS INC | 760273102 | 2,966,674 | $35.8M | 14.20% |
| 3 | CULLINAN ONCOLOGY INC | CGEM | 3,414,189 | $30.9M | 12.25% |
| 4 | ACELYRIN INC | 00445A100 | 2,262,990 | $23.0M | 9.12% |
| 5 | ORCHARD THERAPEUTICS PLC | 68570P200 | 12,315,654 | $14.0M | 5.56% |
| 6 | LARIMAR THERAPEUTICS INC | LRMR | 3,414,468 | $13.5M | 5.35% |
| 7 | KEROS THERAPEUTICS INC | KROS | 407,633 | $13.0M | 5.15% |
| 8 | IKENA ONCOLOGY INC | 45175G108 | 2,180,934 | $9.4M | 3.74% |
| 9 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 215,000 | $7.7M | 3.04% |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 2,829,712 | $5.6M | 2.21% |
| 11 | MINERALYS THERAPEUTICS INC | MLYS | 568,379 | $5.4M | 2.14% |
| 12 | INOZYME PHARMA INC | 45790W108 | 1,270,027 | $5.3M | 2.11% |
| 13 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,299,359 | $5.1M | 2.03% |
| 14 | BLUEPRINT MEDICINES CORP | 09627Y109 | 92,888 | $4.7M | 1.85% |
| 15 | DIREXION SHS ETF TR | 25460G716 | 225,000 | $4.6M | 1.84% |
| 16 | 2SEVENTY BIO INC | 901384107 | 1,002,007 | $3.9M | 1.56% |
| 17 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 60,000 | $3.4M | 1.36% |
| 18 | OVID THERAPEUTICS INC | OVID | 864,822 | $3.3M | 1.32% |
| 19 | SAGIMET BIOSCIENCES INC | SGMT | 348,842 | $3.1M | 1.22% |
| 20 | OMEGA THERAPEUTICS INC | 68217N105 | 1,055,882 | $2.3M | 0.90% |